Back to SUSQUEHANNA INTERNATIONAL GROUP, LLP SUSQUEHANNA INTERNATIONAL GROUP, LLP

VERAVERA

Showing 8 of 14 quarters

Position history for SUSQUEHANNA INTERNATIONAL GROUP, LLPSUSQUEHANNA INTERNATIONAL GROUP, LLP's holdings in VERA THERAPEUTICS INC

Yes. Susquehanna International Group holds 160,837 shares of VERA (Vera Therapeutics), worth $6.9M, as of its Q2 2026 13F filing. It increased the position by 39,817 shares (+32.9%) from Q1 2026. Susquehanna International Group has held VERA since Q1 2023, across 14 quarterly 13F filings.

Current Value

$6.9M

Current Shares

160,837

Total Value Change

+$6M

Total Shares Change

+141,153

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
160,837
+32.9%
$6.9M0.0%$42.91
35
2026-Q1
Decreased
121,020
-31.5%
$4.9M0.0%$40.23
0
2025-Q4
Increased
176,684
+165.3%
$8.9M0.0%$50.64
44
2025-Q3
Increased
66,607
+8.2%
$1.9M0.0%$29.06
28
2025-Q2
Decreased
61,565
-39.2%
$1.5M0.0%$23.56
0
2025-Q1
Increased
101,279
+277.6%
$2.4M0.0%$24.02
42
2024-Q4
Increased
26,819
+36.3%
$1.1M0.0%$42.29
33
2024-Q3
Increased
19,684
+77.2%
$870,0330.0%$44.20
38

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used